Cargando…
Correction: Interleukin-17 receptor C gene polymorphism reduces treatment effect and promotes poor prognosis of ischemic stroke
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968734/ https://www.ncbi.nlm.nih.gov/pubmed/31934726 http://dx.doi.org/10.1042/BSR-20190435_COR |
Ejemplares similares
-
Interleukin-17 receptor C gene polymorphism reduces treatment effect and promotes poor prognosis of ischemic stroke
por: Tian, Jing, et al.
Publicado: (2019) -
Correction to: A functional polymorphism in the promoter of miR-17-92 cluster is associated with decreased risk of ischemic stroke
por: Huang, Huatuo, et al.
Publicado: (2019) -
Correction: Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2022) -
Correction: Early neurological deterioration in acute ischemic stroke patients after intravenous thrombolysis with alteplase predicts poor 3-month functional prognosis - data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Che, Fengli, et al.
Publicado: (2022) -
Correlation between interleukin-18
promoter -607C/A polymorphism and susceptibility to ischemic
stroke
por: Lu, Jian-xia, et al.
Publicado: (2013)